Graph analytics has become instrumental in uncovering insights across various domains, specifically in social networks. It serves as a crucial tool for analyzing the relationship between users in different online platforms. In this research, we apply methods of social network analysis to examine the communication patterns among participants in an online forum recognized for far-right extremism. Our study demonstrates the actors’ relationships and activities through different aspects of applications over networks. In extensive analysis, we identify the influential actors and map their relationships throughout the course of 76 monthly networks. Moreover, we illustrate the evolution of networks over that period, and their connections with significant events. The findings of this analysis aim to understand the nature of interactions and networks, and to allow practitioners to take necessary precautions to mitigate far-right activities on various online platforms.

Predicting events, ranging from political unrest to disease outbreaks and criminal activities, stands as a pivotal task in proactively addressing emerging challenges. Despite the richness of textual data as a source for event detection, it is challenging to extract contextual information from documents due to their complex structure and the dynamic evolution of events. In response to this challenge, dynamic Graph Neural Networks (GNNs) have emerged as a promising tool for capturing the intricate patterns embedded within textual data graphs. Nevertheless, many models in this domain primarily rely on local node-level representations, overlooking the essential global graph-level context. However, both node-level and graph-level representations are critical for effective event prediction. Node-level representations provide insight into the local structure, while graph-level representations offer an understanding of the global structure and the evaluation of temporal graphs. To address these challenges, in this paper, we propose a Dynamic Graph Contrastive Learning (DyGCL) method for event prediction. Our model DyGCL first employs a local view encoder to effectively capture the local dynamic structure of input graphs as the evolving node representations. Then, it performs a global view encoder to perceive the hierarchical dynamic graph representation of the input graphs. Finally, the graph representations from both encoders, optimized via contrastive learning, are combined with an attention mechanism and utilized to predict future events. Our extensive experiments demonstrate that our proposed method outperforms the state-of-the-art methods for event prediction on six real-world datasets.

Modeling the interactions between drugs, targets, and diseases has significant implications for drug discovery, precision medicine and personalized treatments. Current computational approaches consider pairwise interaction, including drug-target or drug-disease interaction individually. On the other hand, within human metabolic systems, the interaction of drugs with protein targets in cells influences target activities. Moving beyond binary relationships and exploring tighter relationships together as triple is essential to understanding drugs' mechanism of action (MoAs). Moreover, considering the heterogeneity of drugs, targets, and diseases, along with their distinct characteristics, it is critical to model these complex interactions appropriately. To address these challenges, we develop a novel Heterogeneous Graph Triplet Attention Network (HeTan)by modeling the interconnectedness of all entities in a heterogeneous graph. HeTAN introduces a novel triplet message passing and triplet-wise attention mechanism within this heterogeneous graph structure. In contrast to focusing only on pairwise attention as the importance of an entity for the other, we define triplet attention to model the importance of pairs for the other in the drug-target-disease triplet prediction problem. We perform extensive experiments on real-world datasets and our results show that HeTAN outperforms several baselines, demonstrating its superior performance in uncovering novel drug-target-disease relationships.